Vaccines for African swine fever: an update

African swine fever (ASF) is a fatal infectious disease of swine caused by the African swine fever virus (ASFV). Currently, the disease is listed as a legally notifiable disease that must be reported to the World Organization for Animal Health (WOAH). The economic losses to the global pig industry h...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongliang Zhang, Saisai Zhao, Haojie Zhang, Zhihua Qin, Hu Shan, Xiulei Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1139494/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850137515732762624
author Hongliang Zhang
Saisai Zhao
Saisai Zhao
Haojie Zhang
Zhihua Qin
Hu Shan
Xiulei Cai
author_facet Hongliang Zhang
Saisai Zhao
Saisai Zhao
Haojie Zhang
Zhihua Qin
Hu Shan
Xiulei Cai
author_sort Hongliang Zhang
collection DOAJ
description African swine fever (ASF) is a fatal infectious disease of swine caused by the African swine fever virus (ASFV). Currently, the disease is listed as a legally notifiable disease that must be reported to the World Organization for Animal Health (WOAH). The economic losses to the global pig industry have been insurmountable since the outbreak of ASF. Control and eradication of ASF are very critical during the current pandemic. Vaccination is the optimal strategy to prevent and control the ASF epidemic, but since inactivated ASFV vaccines have poor immune protection and there aren’t enough cell lines for efficient in vitro ASFV replication, an ASF vaccine with high immunoprotective potential still remains to be explored. Knowledge of the course of disease evolution, the way of virus transmission, and the breakthrough point of vaccine design will facilitate the development of an ASF vaccine. In this review, the paper aims to highlight the recent advances and breakthroughs in the epidemic and transmission of ASF, virus mutation, and the development of vaccines in recent years, focusing on future directions and trends.
format Article
id doaj-art-c642241ef7cd44a3af2eeee7df85b6a8
institution OA Journals
issn 1664-302X
language English
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj-art-c642241ef7cd44a3af2eeee7df85b6a82025-08-20T02:30:49ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2023-04-011410.3389/fmicb.2023.11394941139494Vaccines for African swine fever: an updateHongliang Zhang0Saisai Zhao1Saisai Zhao2Haojie Zhang3Zhihua Qin4Hu Shan5Xiulei Cai6Shandong Collaborative Innovation Center for Development of Veterinary Pharmaceuticals, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, ChinaShandong Collaborative Innovation Center for Development of Veterinary Pharmaceuticals, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, ChinaCollege of Animal Science and Technology, Shandong Agricultural University, Tai’an, ChinaShandong Collaborative Innovation Center for Development of Veterinary Pharmaceuticals, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, ChinaShandong Collaborative Innovation Center for Development of Veterinary Pharmaceuticals, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, ChinaShandong Collaborative Innovation Center for Development of Veterinary Pharmaceuticals, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, ChinaShandong Collaborative Innovation Center for Development of Veterinary Pharmaceuticals, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao, ChinaAfrican swine fever (ASF) is a fatal infectious disease of swine caused by the African swine fever virus (ASFV). Currently, the disease is listed as a legally notifiable disease that must be reported to the World Organization for Animal Health (WOAH). The economic losses to the global pig industry have been insurmountable since the outbreak of ASF. Control and eradication of ASF are very critical during the current pandemic. Vaccination is the optimal strategy to prevent and control the ASF epidemic, but since inactivated ASFV vaccines have poor immune protection and there aren’t enough cell lines for efficient in vitro ASFV replication, an ASF vaccine with high immunoprotective potential still remains to be explored. Knowledge of the course of disease evolution, the way of virus transmission, and the breakthrough point of vaccine design will facilitate the development of an ASF vaccine. In this review, the paper aims to highlight the recent advances and breakthroughs in the epidemic and transmission of ASF, virus mutation, and the development of vaccines in recent years, focusing on future directions and trends.https://www.frontiersin.org/articles/10.3389/fmicb.2023.1139494/fullAfrican swine fever virusepidemic and spreadvaccineprogressreview
spellingShingle Hongliang Zhang
Saisai Zhao
Saisai Zhao
Haojie Zhang
Zhihua Qin
Hu Shan
Xiulei Cai
Vaccines for African swine fever: an update
Frontiers in Microbiology
African swine fever virus
epidemic and spread
vaccine
progress
review
title Vaccines for African swine fever: an update
title_full Vaccines for African swine fever: an update
title_fullStr Vaccines for African swine fever: an update
title_full_unstemmed Vaccines for African swine fever: an update
title_short Vaccines for African swine fever: an update
title_sort vaccines for african swine fever an update
topic African swine fever virus
epidemic and spread
vaccine
progress
review
url https://www.frontiersin.org/articles/10.3389/fmicb.2023.1139494/full
work_keys_str_mv AT hongliangzhang vaccinesforafricanswinefeveranupdate
AT saisaizhao vaccinesforafricanswinefeveranupdate
AT saisaizhao vaccinesforafricanswinefeveranupdate
AT haojiezhang vaccinesforafricanswinefeveranupdate
AT zhihuaqin vaccinesforafricanswinefeveranupdate
AT hushan vaccinesforafricanswinefeveranupdate
AT xiuleicai vaccinesforafricanswinefeveranupdate